Sexually Transmitted Diseases


Bacterial Vaginosis

Bradshaw, C., Morton, A., Garland, S., et al. (2005). Evaluation of a point-of-care test, BVBlue, and clinical and laboratory criteria for diagnosis of bacterial vaginosis. Journal of Clinical Microbiology. 43(1304).

Centers for Disease Control and Prevention. (2014). Bacterial vaginosis-CDC Fact Sheet. Retrieved March 22, 2018, from: http://www.cdc.gov/std/bv/stdfact-bacterial-vaginosis.htm 

Centers for Disease Control and Prevention. (2015). 2015 Sexually transmitted disease treatment guidelines. Retrieved March 22, 2018, from: http://www.cdc.gov/std/tg2015/bv.htm 

Donders, G. (2010). Diagnosis and management of bacterial vaginosis and other types of abnormal vaginal bacterial flora: A review. Obstetric and gynecological survey. 65(7); 462-473

Dugoua, J.J., Machado, M., Zhu, X., Chen, X., Koren, G., & Einarson, T.R. (2009). Probiotic safety in pregnancy: a systematic review and meta-analysis of randomized controlled trials of Lactobacillus, Bifidobacterium, and Saccharomyces species. Journal of Obstetrics and Gynaecology. 31(6): 542-52.

Evans, A., Scally, A., Wellard, S., & Wilson, J. (2007). Prevalence of bacterial vaginosis in lesbians and heterosexual women in a community setting. Sexually Transmitted Infection. 83 (470).

Fethers, K., Fairley, C., Hocking, J., et al. (2008). Sexual risk factors and bacterial vaginosis: a systematic review and meta-analysis. Clinical Infectious Disease 47 (1426).

Klebanoff M.A., Nansel, T.R., Brotman, R.M., Zhang, J., Yu, K., Schwebke J.R., & Andrews, W.W. (2010). Personal hygienic behaviors and bacterial vaginosis. Sexually Transmitted Diseases. 37 (2): 94-99.

Muzny, C. and Schwebke, J. (2016). Pathogenesis of Bacterial Vaginosis: Discussion of Current Hypotheses. Journal of Infectious Disease. 214 (1).

Ness, R. Hillier, S., Richter, H., et al. (2002). Douching in relation to bacterial vaginosis, lactobacilli, and facultative bacteria in the vagina. Obstetrics and Gynecology. 100 (765).

Sobel, J.D. (2017). Bacterial vaginosis: Clinical manifestations and diagnosis. UpToDate. Retrieved March 22, 2018, from: https://www.uptodate.com/contents/bacterial-vaginosis-clinical-manifestations-and-diagnosis


Chlamydia

Centers for Disease Control and Prevention. Chlamydia. Retrieved Dec. 4, 2017, from: https://www.cdc.gov/std/chlamydia/default.htm

Centers for Disease Control and Prevention. Sexually Transmitted Diseases Treatment Guidelines, 2015. MMWR Recomm Rep 2015; 64 (No. RR-3):1-137.

Centers for Disease Control and Prevention. Sexually transmitted diseases surveillance 2016. Retrieved Dec. 4, 2017, from: https://www.cdc.gov/std/stats16/default.htm 

National Center for Health Statistics. National Center for Health Statistics Reports. No. 105. Condom Use During Sexual Intercourse Among Women and Men Aged 15–44 in the United States: 2011–2015 National Survey of Family Growth. 18 pp. (PHS) 2017-1250. August 10, 2017. Retrieved Dec. 4, 2017, from https://www.cdc.gov/nchs/products/nhsr.htm. 

Rours, G. I. J., Duijts, L., Moll, H. A., Arends, L. R., de Groot, R., Jaddoe, V. W., & Willemse, H. F. (2011). Chlamydia trachomatis infection during pregnancy associated with preterm delivery: a population-based prospective cohort study. European Journal of Epidemiology, 26(6), 493-502.

U.S. Preventive Services Task Force. Final Recommendation Statement: Chlamydia and Gonorrhea Screening. Retrieved Dec. 4, 2017, from: https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/chlamydia-and-gonorrhea-screening


Genital Herpes

Agyemang, E., Le, Q.A., Warren, T., Magaret, A.S., Selke, S., Johnston, C., Jerome, K.R., Wald, A. (2017.) Performance of Commercial Enzyme-Linked Immunoassays for Diagnosis of Herpes Simplex Virus-1 and Herpes Simplex Virus-2 Infection in a Clinical Setting. Sexually Transmitted Diseases, 44 (12):763-767. doi: 10.1097/OLQ.0000000000000689.

Centers for Disease Control and Prevention (2015). Sexually Transmitted Diseases Treatment Guidelines, 2015. MMWR Recomm Rep 2015; 64 (No.RR-3):1-137. Retrieved Dec. 7, 2017, from: https://www.cdc.gov/std/tg2015/default.htm

Centers for Disease Control and Prevention (2017). Genital Herpes Treatment and Care. Retrieved Dec. 7, 2017, from https://www.cdc.gov/std/herpes/treatment.htm 

Filén, F., Strand, A., Allard, A., Blomberg, J., & Herrmann, B. (2004). Duplex real-time polymerase chain reaction assay for detection and quantification of herpes simplex virus type 1 and herpes simplex virus type 2 in genital and cutaneous lesions. Sexually Transmitted Diseases, 31(6), 331-336.

Finger-Jardim, F., Avila, E.C., da Hora, V.P., Gonçalves, C.V., de Martinez, A.M.B., Soares, M.A. (2017.) Prevalence of herpes simplex virus types 1 and 2 at maternal and fetal sides of the placenta in asymptomatic pregnant women. American Journal of Reproductive Immunology, 78(1). doi: 10.1111/aji.12689. Epub 2017 Apr 25.

Martin, E. T., Krantz, E., Gottlieb, S. L., Magaret, A. S., Langenberg, A., Stanberry, L., & Wald, A. (2009). A pooled analysis of the effect of condoms in preventing HSV-2 acquisition. Archives of Internal Medicine, 169(13), 1233-1240.

Medical Express. (2017.) Exploring how herpes simplex virus changes when passed between family members. Medical Express website. Retrieved Dec. 7, 2017, from https://medicalxpress.com/news/2017-10-exploring-herpes-simplex-virus-family.html

Ramchandani, M., Selke, S., Magaret, A., Barnum, G., Huang, M.W., Corey, L., Wald, A. (2017.) Prospective cohort study showing persistent HSV-2 shedding in women with genital herpes 2 years after acquisition. Sexually Transmitted Infections. doi: 10.1136/sextrans-2017-053244. [Epub ahead of print]

Thellman, N.M., Triezenberg, S.J. (2017.) Herpes Simplex Virus Establishment, Maintenance, and Reactivation: In Vitro Modeling of Latency. Pathogens, Jun 23;6(3). pii: E28. doi: 10.3390/pathogens6030028.

Tobian, A. A., Kigozi, G., Redd, A. D., Serwadda, D., Kong, X., Oliver, A., & Wawer, M. J. (2012). Male circumcision and herpes simplex virus type 2 infection in female partners: a randomized trial in Rakai, Uganda. Journal of Infectious Diseases, 205(3), 486-490.

World Health Organization. (2017.) Herpes Simplex Virus. Retrieved Dec. 7, 2017, from http://www.who.int/mediacentre/factsheets/fs400/en/


Gonorrhea

Centers for Disease Control and Prevention. (2015). Sexually Transmitted Diseases Treatment Guidelines, 2015. MMWR Recomm Rep 2015; 64 (No.RR-3):1-137. Retrieved March 22, 2018, from: https://www.cdc.gov/std/tg2015/toc.htm 

Centers for Disease Control and Prevention. (2015). Expedited Partner Therapy (EPT). Retrieved March 22, 2018, from: http://www.cdc.gov/std/ept/ 

Lo, J., K. Ho, and A. Lo. (2012). Surveillance of gonococcal antimicrobial susceptibility resulting in early detection of emerging resistance. The Journal of Antimicrobial Chemotherapy 67 (6): 1422-1426.

Wong, B., Chandrasekar, P., Ammar, N., et al. (2017). Gonorrhea Treatment and Managment. Medscape. Retrieved March 22, 2018, from: http://emedicine.medscape.com/article/218059-overview#showall 


Human Papillomavirus


Albero, G., Castellsagué, X., Giuliano, A. R., & Bosch, F. X. (2012). Male circumcision and genital human papillomavirus: a systematic review and meta-analysis. Sexually Transmitted Diseases, 39(2), 104-113.

Castle, P. E., & Katki, H. A. (2010). Benefits and risks of HPV testing in cervical cancer screening. Lancet Oncology, 11(3), 214-215.

Centers for Disease Control and Prevention. (2017.) Human Papillomavirus Statistics. Retrieved Dec. 7, 2017, from https://www.cdc.gov/std/hpv/stats.htm

Centers for Disease Control and Prevention. (2015.) Sexually Transmitted Diseases Treatment Guidelines, 2015. MMWR Recomm Rep, 64(No.RR-3):1-137.

Centers for Disease Control and Prevention. (2016.) What Is HPV? Retrieved Dec. 7, 2017, from https://www.cdc.gov/hpv/parents/whatishpv.html

Chaturvedi, A.K., Graubard, B.I., Broutian, T., Pickard, R.K.L., Tong, Z.Y., Xiao, W., Kahle, L., Gillison, M.L. (2017.) Effect of Prophylactic Human Papillomavirus (HPV) Vaccination on Oral HPV Infections Among Young Adults in the United States. Journal of Clinical Oncology. doi: 10.1200/JCO.2017.75.0141.

Goldstone, S., Palefsky, J. M., Giuliano, A. R., Moreira, E. D., Aranda, C., Jessen, H., & Marshall, J. B. (2011). Prevalence of and risk factors for human papillomavirus (HPV) infection among HIV-seronegative men who have sex with men. Journal of Infectious Diseases, 203(1), 66-74.

Hariri, S., Unger, E. R., Sternberg, M., Dunne, E. F., Swan, D., Patel, S., & Markowitz, L. E. (2011). Prevalence of genital human papillomavirus among females in the United States, the National Health and Nutrition Examination Survey, 2003-2006. Journal of Infectious Diseases, 204(4), 566-573.

Kidd L.C., Chaing, S., Chipollini, J., Giuliano, A.R., Spiess, P.E., Sharma, P. (2017.) Relationship between human papillomavirus and penile cancer-implications for prevention and treatment. Translational Andrology & Urology, 6(5):791-802. doi: 10.21037/tau.2017.06.27.

Larke, N., Thomas, S. L., dos Santos Silva, I., & Weiss, H. A. (2011). Male circumcision and human papillomavirus infection in men: a systematic review and meta-analysis. Journal of Infectious Diseases, 204(9), 1375-1390.

Machalek, D. A., Poynten, M., Jin, F., Fairley, C. K., Farnsworth, A., Garland, S. M., & Templeton, D. J. (2012). Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. The Lancet Oncology, 13(5), 487-500.

Moyer, V.A. (2012). U.S. Preventive Services Task Force. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement. Annals of Internal Medicine, 156, 880.

Ronco, G., Franceschi, S. (2017.) Cervical Cancer Screening: The Transformational Role of Routine Human Papillomavirus Testing. Ann Intern Med. doi: 10.7326/M17-2872. [Epub ahead of print]


Pelvic Inflammatory Disease

British Association for Sexual Health; HIV/Medical Foundation for Aids & Sexual Health (2010). Standards for the management of sexually transmitted infections. Retrieved Jan. 7, 2018, from: http://www.medfash.org.uk/uploads/files/p18dtqli8116261rv19i61rh9n2k4.pdf

Centers for Disease Control and Prevention. (2015). Pelvic Inflammatory Disease Treatment and Care. Retrieved Jan. 7, 2018, from: https://www.cdc.gov/std/pid/treatment.htm 

Centers for Disease Control and Prevention. (2014). Pelvic Inflammatory Disease (PID) Statistics. Retrieved Jan. 7, 2018, from: http://www.cdc.gov/std/pid/stats.htm

Centers for Disease Control and Prevention. (2015). Sexually Transmitted Diseases Treatment Guidelines, 2015. MMWR Recomm Rep 64(No.RR-3):1-137.

Curtis, K.M., Tepper, N.K, Jatlaoui, T.C, et al. (2016). U.S. Medical Eligibility Criteria for Contraceptive Use. MMWR Recomm Rep. 65(No. RR-3):1-104. doi: http://dx.doi.org/10.15585/mmwr.rr6503a1. Retrieved Jan. 7, 2018, from: https://www.cdc.gov/mmwr/volumes/65/rr/rr6503a1.htm

Leichliter, J. S., Chandra, A., & Aral, S. O. (2013). Correlates of self-reported pelvic inflammatory disease treatment in sexually experienced reproductive-aged women in the United States, 1995 and 2006-2010. Sexually Transmitted Diseases, 40(5), 413-418.

Shepherd, M.S. (2017). Pelvic Inflammatory Disease Treatment & Management. Retrieved Jan. 7, 2018, from:  https://emedicine.medscape.com/article/256448-treatment


Syphilis

Brian Euerly, M. F., Bronze, MD, M. S., & Hogan, MD, D. J. (2014). Syphilis Differential Diagnoses. Medscape. Retrieved March 22, 2018, from: https://emedicine.medscape.com/article/229461-differential

Centers for Disease Control and Prevention. (2015). Expedited Partner Therapy (EPT). Retrieved March 22, 2018, from: http://www.cdc.gov/std/ept/ 

Centers for Disease Control and Prevention. (2015). 2015 STD Treatment Guidelines: Syphilis. Retrieved March 22, 2018, from: http://www.cdc.gove/std/tg2015/syphilis.htm

Frelick, M., Vega, C. (2016). USTSPF Updates Syphilis Guidelines. Medscape Multispecialty. Retrieved March 22, 2018, from: http://www.medscape.org/viewarticle/865393 

Hicks, C.B. (2017). Syphilis: treatment and monitoring. UpToDate. Retrieved March 22, 2018, from: https://www.uptodate.com/contents/syphilis-treatment-and-monitoring

Hook, E., Behets, F., Damme, K., Ravelomanana, N., Leone, P., Sena, A., Martin, D., Langley, C., McNeil, L., Wolff, M. (2010). A Phase III Equivalence Trial of Azithromycin versus Benzathine Penicillin for Treatment of Early Syphilis,.The Journal of Infectious Disease. 201 (11): 1729-1735.

Rac, M.W., Bryant, S., Cantey, J., McIntire, D., Sheffield, J. (2015). Maternal titers aftera adequate syphilotherapy during pregnancy. Cinical Infectious Disease, 60 (5): 686-690.

Ramsey, P. S. (2014). Editorial Commentary: Post-Syphilotherapy Titers in Pregnancy. Retrieved March 22, 2018, from: https://cid.oxfordjournals.org/content/60/5/691.full 


Trichomoniasis

Bandea, C. I., Joseph, K., Secor, E. W., et al. (2013). Development of PCR assays for detection of Trichomonas vaginalis in urine specimens. Journal of Clinical Microbiology, 51(4), 1298-1300.

Bouchemal, K., Bories, C., Loiseau, P.M. (2017). Strategies for Prevention and Treatment of Trichomonas vaginalis Infections. Clin Microbiol Rev. 30(3): 811-825. doi: 10.1128/CMR.00109-16.

Centers for Disease Control & Prevention. (2015). 2015 Sexually Transmitted Diseases Treatment Guidelines. Trichomoniasis Retrieved Jan. 18, 2018, from http://www.cdc.gov/std/tg2015/trichomoniasis.htm .

Centers for Disease Control and Prevention. (2015). 2015 Sexually Transmitted Diseases Treatment Guidelines. MMWR Recomm Rep 64 (No. RR-3):1-137.

Howe, K., Kissinger, P. (2017). Single-Dose Compared With Multidose Metronidazole for the Treatment of Trichomoniasis in Women: A Meta-Analysis. Sex Transm Dis, 44(1):29-34.

Follow Us

Contact Us

  • Address: 148-B Banks Ave | Lafayette, LA, 70506

  • Phone: (800) 899-4502

  • Email: questions@apea.com

Accreditation

Advanced Practice Education Associates is an approved provider of nurse practitioner continuing education by the American Association of Nurse Practitioners.
AANP Provider #100820